Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0.646. It has been cited 73 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.646
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P50CA221747
National Institutes of Health
Grant: R35CA197725
National Institutes of Health
Grant: R01NS093903
National Institutes of Health
Grant: R01 NS087990
National Cancer Institute
Grant: P30 CA060553
National Cancer Institute
Grant: P30-CA060553
National Institute of Neurological Disorders and Stroke
Grant: R33 NS101150
National Institute of Neurological Disorders and Stroke
Grant: R01 NS106379
National Cancer Institute
Grant: CA060553
NINDS NIH HHS
Grant: R01 NS102669
NINDS NIH HHS
Grant: R01 NS117104
NCATS NIH HHS
Grant: UL1 TR001422
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Institutes of Health
Grant: 4R33NS101150-03
Neural Stem Cell Carriers for Glioblastoma Immunotherapy
National Institutes of Health
Grant: 5R01NS087990-02
Intranasal Stem-Cell Based Therapy for Glioblastoma
National Institutes of Health
Grant: 5P50CA221747-02
SPORE for Translational Approaches to Brain Cancer
National Institutes of Health
Grant: 5R01NS093903-04
Metabolic Control of Immune Suppression in Gliomas
National Institutes of Health
Grant: 5R01NS106379-03
Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy
National Institutes of Health
Grant: 1R35CA197725-01
Therapeutic Targeting of Malignant Glioma Stem Cells
FWCI
2.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals